痴呆症护理研究和心理社会因素
1University of Washington, Seattle, WA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
这项研究开发了一种基于选择的工具,以了解痴呆症患者 (PWD) 和他们的护理伙伴 (CP) 的护理偏好. 该工具旨在改善随着痴呆症进展的共享决策.
科学领域:
- 老年学是一门学科.
- 痴呆症护理研究研究
- 医疗信息学 医疗信息学
背景情况:
- 患有痴呆症的老年人经常被排除在护理决策之外,特别是在晚期阶段.
- 阿尔茨海默病研究决策 (DMAR) 项目通过NIH资金解决了这一差距.
- 该项目重点是创建一个工具,以了解痴呆症患者 (PWD) 和他们的护理伙伴 (CP) 的护理偏好.
研究的目的:
- 为PWD和CP设计和开发一个可访问的,基于选择的工具.
- 为了更好地理解和比较PWD和CP关于支持性护理决定的偏好.
- 促进在痴呆症护理中的共享决策.
主要方法:
- 利用培训工作,包括与PWD,CP和医疗保健提供者进行深入采访.
- 应用以人为中心的设计 (HCD) 原则和大声思考的方法.
- 开发了一种离散选择实验 (DCE) 仪器,并对131个二进行了为期12个月的纵向研究.
主要成果:
- 成功开发并为131名PWD和CP双人组使用了DCE仪器.
- 目前正在分析基线和6个月数据,以比较权重偏好.
- 识别随着时间的推移在PWD和CP之间偏好的变化.
结论:
- 一个以人为中心的方法使得成功开发和管理一个DCE仪器用于纵向二研究.
- 该研究将分享包容性招聘的策略以及以痴呆为中心的设计对数据分析的影响.
- 计划探索新技术,以提高老年痴呆症患者的参与度.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
